[go: up one dir, main page]

GB2223027A - Periodontium regenerating materials - Google Patents

Periodontium regenerating materials Download PDF

Info

Publication number
GB2223027A
GB2223027A GB8918343A GB8918343A GB2223027A GB 2223027 A GB2223027 A GB 2223027A GB 8918343 A GB8918343 A GB 8918343A GB 8918343 A GB8918343 A GB 8918343A GB 2223027 A GB2223027 A GB 2223027A
Authority
GB
United Kingdom
Prior art keywords
lactide
copolymer
caprolactone
periodontium
glycolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8918343A
Other versions
GB2223027B (en
GB8918343D0 (en
Inventor
Yoshito Ikada
Shokyu Gen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Corp
Original Assignee
GC Dental Industiral Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GC Dental Industiral Corp filed Critical GC Dental Industiral Corp
Publication of GB8918343D0 publication Critical patent/GB8918343D0/en
Publication of GB2223027A publication Critical patent/GB2223027A/en
Application granted granted Critical
Publication of GB2223027B publication Critical patent/GB2223027B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/50Preparations specially adapted for dental root treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Dental Preparations (AREA)

Description

1 1 r)r r3027 A24 PERIODONTIUM-REGENERATIVE MATERIALS The present
invention relates to a bi odegradabl e /absorbable dental material required for the regeneration of the tissues of a living body attacked by periodontosis.
In current periodontal treatments of healthy cementum and periodontal ligament attacked by periodontal diseases, hydroxyapatite and calcium phosphate are used as the alveolar bone fillers to be filled in lost periodontal tissues.
However, such treatments are considered to be only effective to prevent periodontal diseases from reaching an advanced stage or recurring to some degrees. In recent years, the Guided Tissue Regeneration Technic developed by Professor S. Nyman et al (University of Gothenburg) from a biological standpoint of view has attracted attention in dental fields. For such epoch-making Guided Tissue Regeneration Technic, it has been reported that certain results are achievable with what is called Goretex membrane which is neither degradable nor absorbable in a living body. See S. Nyman et a!, "The regenerative potential of the periodontal ligament - An experimental study in the monkey", J. Clin. Periodontol, 9:257, 1982.
Since Coretex membrane is neither degradable nor absorbable in a living body, it constitutes an alien substance to the living body and is reactive to the tissues. Therefore we must take off Coretex membrane after first treatment and second operation is thus again needed. From such a standpoint of view, a report of the studies of using biodegradable/absorbable membranes for the Guided Tissue Z 1 - Z Regeneration Technic has been presented. See I. Magnusson et al, Attachment Formation Following Controlled Tissue Regeneration Using Biodegradable Membranes% J. Periodontol, 59, 1-6, January, 1988.
However. since a homopolymer consisting of 100 % polylactic acid is used as the bio-degradable/absorbable membrane, it is impossible to control both dynamic (or mechanical) properties and a rate of hydrolysis simultaneously.
Due to its glass transition temperature higher than a temperature of a body, the homopolymer consisting of 100 polylactic acid gives a physical stimulus to the soft tissues of a -living body with the resulting inducement of inflammation. With the homopolymer, it is difficult to freely vary the rate of hydrolysis.
The present inventors have made intensive and extensive studies to eliminate the weak points of the above homopolymer of polylactic acid, i. e., to improve especially its dynamic (or mechanical) properties, thermal properties, and the rate of hydrolysis. As a consequence, it has been found that a film or sheet of a lactide/Ecaprolactone or a glycolide copolymer is best-suited for the Guided Tissue Regeneration Technic. Thus, the present invention has been accomplished.
The present invention provides a pe.:iodontium-regenerating material which is a bio-degradable/absorbable high-molicular material, and preferably uses a lactide/r-caprolactone- or a glycolide copolymer as the biodegradable /absorbable high-molecular materials applied to the Guided Tissue Regeneration Technic to be effective to prevent periodontal diseases. Such bio-degradablejabsorbable materials may be formed into films or sheets by dissolving the lactide/ c -caprolactone or lac tide /glycol ide copolymers in a solvent such as an organic solvent, e.g., methylene chloride, chloroform, dioxane toluene, benzene, dime thyl formami de, or acetone and subjecting the resulting solutions to 1 1 casting or hot pressing. In order to allow such films or sheets to transmit body fluids such as nourishment therethrough or give flexibility thereto, they may be made porous by stretching or freezedrying treatment in benzene or dioxane solution.
The bio-degradable/absorbable high-molecular materials according to the present invention excel in not only flexibility but also biocompatibility. Thus, they tend to disappear immediately after a cure of injured sites with no fear of interfering with the bony ankylosis of the connective tissue separated from a surface of a root by discission or lesion. The reason why such excellent biocompatibility is obtained is that it is possible to use materials whose dynamic and thermal properties as well as the rate of hydrolysis can be varied by the copolymerization of lactide that is an aliphatic polyester with e-caprolactone or glycolide used in suitable ratios and that the materials can be selected in application depending upon how much the injured sites are to be cured.
The present invention will now be explained in more detail with reference to the accompanying drawings, which are given for the purpose of illustration alone and in which: - Figure 1 is a graph. showing the relation between the molar fraction of e-caprolactone in the copolymer of L- lactide/ecaprolactone and the glass transition temperature of that copolymer; Figure 2 is a graph illustrating the relation between the molar fraction of --caprolactone in the copolymer of L-lactide/e - caprolactone and the dynamic modulus of elasticity thereof at room temperature; Figure 3 is a graph showing the relation between the time of hydrolysis and the weight and rate of residual molecular weight of the copolymer of L-lactide/F,-caprolactone; and A Figure 4 is a graph. showing the relation between the time of hydrolysis and the tensile strength of the copolymer of Llactide/e -caprolactone.
The bio-degradable /absorbable high-molecular materials used in the present invention are widely distributed in the natural world and are a copolymer of lactide/r;-caprolactone or lac tide /glycol ide found in the bodies of animals. The composition and molecular weight of such a copolymer may be selected depending upon the mechanical properties and bio-degradinglabsorbing rate of material suitable for the condition of a periodontal disease. The lac tide/ c caprolac tone copolymers used in the present invention are synthesized according to the following scheme.
L - lactide monorner Tm.960C D,L - lactide monaner Tm.1280C DIL - lactide, L-lactide CH, 1 OH-C-COOH 1 H CH, 1 -41 O-C-C 1 11 H - 3HC 0 HC _+ 1 O=C C=0 1 CH C H, n 0 ú -caprolactene :2 H C - (C HA.
1 1 U-(-;=U , - caprolactcne mancmer Tm. -50C Ring opening polymerization 3 lic 0 HC C-0 1 1 + U-G CH 0 c H, lactide-caprolactcne ccpolymer 2 H C -(C II, 1 1 U-(J=U CH3 0 1 11 O-CH - 1901C 1 Shours C H, 0 k 1 The copolymers of lactide/glycolidc- used in the T)resent inventinn are synthesized according to the following schmme.
3fIC 0 H C C=O I. I O=C C H \ 0 / \ C H, lactide 0 H2 G=0 + 1 1 O=C UM, 0 Glycolide fl 0-(CH2)3-0 11 U CH, 0 O-CH-0-( CH, U 0 11 O-CH2-0-C-CH.,-C11 U lactictelglicolide copolymer 0 v n 1 1 1 1 The bio-degradable /absorbable high-molecular materials used in the present invention come in touch with the soft tissues of a living body, and axe thus required to have some flexibility, since inflammatory reactions are induced by physical stimuli at the time when there is a large difference between dynamic properties of such materials and those of the soft tissues of a living body, especially, when their hardness is in excess. In order to accomplish this aim, it is preferred that their glass transition temperature is in the vicinity o! a temperature of a body. To meet such a requirement, it is required to select the composition of the lac tide/ r; -caprolac tone or the lactide/glycolide copolymers according to suitable compositional ratios. Figure I illustrates a change in the glass transition temperature on the molar fraction of e-caprolactone in the copolymer of lactide / e -caprolac tone. It is understood that the measurement of glass transition temperature was carried out with a differential scanning calorimeter (DSC) - marked by & and a dynamic modulus meter - marked by 0.
The bio-degradable /absorbable high-molecular materials used in the present invention are required to have a certain dynamic strength. In other words, when there is a need of fixing the biodegradable /absorbable films or sheets to a given region with a suture, a grave problem will arise if the fixed part tears up. In the absence of a certain strength or modulus of elasticity, on the other hand, it poses a problem in connection with the retainment of shape tending to change due to hydrolysis, so that the desired object cannot be attained. Therefore, the materials used in the present invention should preferably have a dynamic modulus in a range of 5 x 101 to 5 X 10s dynes/cm' that is attainable by the selection of the composition of the copolymers. Figure 2 illustrates a change at room temperature in the dynamic modulus of elasticity on the molar fraction P of r--caprolactone in the copolymer of L-lactide/s -caprolactone. lt is understood that the dynamic modulus of elasticity was measured with RheoVibron available from Toyo Balldwin.
On the one hand, the bio-degradable /absorbable high-molecular materials used in the present invention should be retained in the form of a film or a sheet within a period during which the regeneration of the alveolar bone and the recombination of the surface of a root with the connective tissue are achieved. On the other hand, it is not desirable that they remain as an alien substance in a living body after curing. Thus, they are required to be rapidly degraded, absorbed and disappeared. The degradable /absorbable rate can also be controlled by varying a composition and a molecular weight of the copolymers.
Changes in the in-vitro hydrolysis on the molar fraction of e caprolactone in the copolymer of L-lactide/,- -caprolactone therein are illustrated in Figures 3 and 4, wherein 0 stands for 100 % L-lactide molecular weight, D 88 % L-lactide molecular weight, A 65 % Llactide molecular weight, @ 15 % Llactide molecular weight, x 100 % a - caprolactone molecular weight, & 100 % L-lactide mass, a 88 % L-lactide mass, and A 65 01. L-lactide mass. The rate of hydrolysis of samples in the in-vitro were estimated in a solution having a certain volume (3 mm long x 5 mm wide x 1 mm thick) in a phosphate buffer solution of 37 'C (pH 7.4) with an elution tester according to THE PHARMACOPOEIA OF JAPAN. The weight, molecular mass and the rate of reductions of tensile strength of the hydrolysated products were measured before and after hydrolysis and expressed in terms of percentage.
Then, the bi o-degradable /absorbable rates and reactivity to a tissue were investigated by in-vivo tests. The dorsal muscles of house rabbits, each weighing about 3 kg, were incised along the fibrous direction, the samples were filled, and the fasciae were then sutured. Prior to the filling, the samples were sterilized with an ethylene oxide gas. After the filling, the rabbits were slaughtered with the lapse of time to examine changes in the physical properties of the samples and the reactivity of the peripheral tissues. As a consequence, the homopolymer consisting of 100 % polylactic acid remained substantially in its entirety even after the lapse of six months and the soft tissue in touch with the periphery of the material suffered from some inflammation. However, the copolymers of lactide/is caprolac tone (at a molar ratio of 70:30 mol %) and lactide /glycol i de (at a molar ratio of 75:25 mol %) were completely degraded and absorbed with no sign of any tissular reaction.
From the above results, it is appreciated that the copolymers of lac tide/ E, -caprol actone and lactide /glycol ide are superior to the homopolymer consisting of 100 % polylactic acid in the dynamic properties and the rate of hydrolysis as well as the biocompatibility. The copolymers of lacti de / c -caprolac tone and lactide/glycolide are interesting materials since, as is the case with the homopolymer consisting of 100 % polylactic acid, they cause non-enzymatical hydrolysis in a living body to give hydrolyzates which are degraded and absorbed and finally discharged from the living body in the form of water and carbon dioxide. Thus, the bio-degradable/absorbable highmolecular materials according to the present invention are not only useful materials for the Guided Tissue Regeneration Technic, but are also clinically useful materials in other dental fields.
The biodegradable/absorbable high-molecular materials of the present invention will now be explained specifically but not exclusively with reference to the following examples.
Example 1
A fully developed mongrel was forcedly made to suffer from a k 1 periodontal disease, thereby inducing gingival retraction. The biodegradable /absorbable porous film was used in the form of an about 200pm thick sheet consisting of a L-lac tide/ E -caprolactone copolymer (at a molar ratio of 70:30 mol %) having a weight-average molecular weight of about 220,000 as well as a dynamic modulus of elasticity of 9.5 x 107 dynes /CM2 and anelongation rate of 150 Z, both at room temperature (25 'C) - Af ter the surface of the root had been covered with such the sheet in a form of a patched tent, a flap of the gingival tissue was backsutured to prevent the connective tissue from coming in contact with the surface of the root and taking part in the process of healing. After the lapse of three months, the process of healing was observed. As a result, the L-lac tide/ F_ -caprolactone copolymer was found to lose a substantial part of its dynamic strength and cause considerable hydrolysis, although its shape was remained. However, new attachment including a formation of the new alveolar bone indicated that the periodontal disease was cured.
Example 2
As the bio-degradable/absorbable film, use was made of an about 180pm thick film-like material consisting of a D, L-lactide /glycol ide copolymer (at a molar ratio of 80:20 mol Z) having a weight-average molecular weight of 170,000 as well as a dynamip modulus of elasticity 9. 8 x 10 dynes/cml and anelongation rate of 200 Z, both at room temperature (25 'C). According to the procedures of Example 1, the process of healing was estimated after the lapse of three months. As a consequence, it was found that the film consisting of the D,Llactide/glycolide copolymer was substantially degraded and absorbed, and that the periodontal ligament fibers were formed simultaneously with the formation of a new bone, a sign of healing of the periodontal disease.
1 Example 3
A 10 % dioxane solution of a L-lactide/glycolide copolymer (at a molar ratio of 90:10 mol %) having a weight-average molecular weight of about 260,000 as well as a dynamic modulus of elasticity of 1.8 x 108 dynes/cm2 and aK elongation rate of 1000 both at room temperature (25 "C) was freeze-dried to prepare a biodegradable/absorbable porous film in the form of an about 220pm sheet.
With this film, an animal experiment was performed in a similair manner as described in Example 1. After the lapse of three months, it was found that the porous sheet-like film consisting of the L lactide/glycolide copolymer was completely degraded and absorbed with a healing of periodontal disease.
Example 4
A 10 % dioxane solution of a D,L-lactide/glycolide copolymer (at a molar ratio of 75:25 mol %) having a weight-average molecular weight of about 190,000 as well as a dynamic modulus of elasticity of 3.2 x 108 dynes/cm' and an elongation rate of 1500 %, both at room temperature (25 C) was freeze-dried to prepare a biodegradable/absorbable porous film in the form of an about 160pm sheet. With this film, an animal experiment was performed in a similar manner as described in Example 1. After the lapse of three months, it was found that the porous sheet-like film consisting of the D,Llactide/glycolide copolymer was completely degraded and absorbed with a healing of periodontal disease.
Comparative Example 1 An experiment was performed according to Example 1, provided that an about 200pm thick material consisting of polylactic acid having a molecular weight of about 220,000 was used as the biodegradable/absorbable film, to observe the degree of healing after the lapse of three months. As a result, it was found that the polylactic i; 1 acid film was not substantially degraded with the inducement of partial inflammation in the gingival tissue in touch with the edges of the film consisting of 100 % polylactic acid.
The bio-degradable /absorbable high-molecular materials of the present invention have the following advantages in comparison with the highmolecular materials which are neither degradable nor absorbable in a living body.
According to the Guided Tissue Regeneration Technic proposed by Professor S. Nyman et al (University of Gothenburg), it is essentially required to remove the material inplanted in the periodontium immediately after the periodontium are found to be healed by such imp:Lant. For such removal, it is again necessary to perform an operation. With the biodegradable/absorbable high-molecular materials of the present invention, however, it is unnecessary to perform a reoperation, thus easing a patient of pain and relieving an economical burden to considerable degrees.
The material implanted in the periodontium is required to have strength at the beginning, but is rather needed to lose that strength after the healing of the periodontal disease. No change in strengh tends to induce inflammation. However, the bio-de gradable /absorbable high-molecular materials of the present invention have strength at the start, which can be decreased gradually or sharply with the lapse of time, and so there is no possibility of inducing inflammation in the periodontium.
Moreover, the bio-degradable/absortable high-molecular materials of the present invention have the following advantages in comparison with those consisting of homopolymers of 100 % polylactic acid.
The dynamic/mechanical properties suitable for the conditions of the periodontium can be given to the bio-degradable/absorbable highmolecular materials of the present invention because the materials Z.
A consist of the copolymers of lactide/e -caprolactone or lactide/glycolide. It is required to vary the rates of biodegradation and -absorption of the material nplanted in the periodontium depending upon the degree of periodontal disease. Especially when it is intended to decrease sharply the dynamic /mechanical properties of the bio-degradable /absorbable highmolecular materials at the time when a certain period of time elapses after its Inplant in the periodontium, difficulty is involved in freely varying the rate of hydrolysis of the bio-degradable/absorbable high- molecular material consisting of the homopolymer of 100 % polylactic acid. With the bio-degradablelabsorbable high-molecular materials of the present invention, however, it is possible to freely control their rates of degradation and absorption.
Further, the bio-degradable/absorbable high-molecular materials of the present invention give little or no physical stimuli to the soft tissues of a living body because their glass transition temperature is in the vicinity of body heat in comparison with the biodegradable/absorbable materials consisting of the homopolymer of 100 polylactic acid.
i 4 1 1 i

Claims (9)

Claims: -
1. A periodontium-regenerating' material for the regenerative treatment of the periodontium, which is a bio-degradable/absorbable high-molecular material.
2. A periodontium-regenerating material as claimed in Claim 1, wherein a copolymer of lactidels -caprolactone or lactide/glycolide is used as said bio-degradable/absorbable high-molecular material.
3. A periodontium-regenerating material as claimed in Claim 2, 19 wherein said copolymer of lactide/s -caprolactone or lactide/glycolide has a weight-average molecular weightAn a range of 40,000 to 500,000.
4. A periodontium-regenerating material as claimed in Claim 2 or -3, wherein said copolymer of lactide/c-caprolactone or lactide/glycolide has a molar ratio in a range of 95:5 to 5:95.
5. A material as claimed in any of claims 2 to 4, wherein said copolymer of lactide/e-caprolactone or lactide/glycolide is in the form of a film or a sheet having a thickness in a range of 10 to 500 pm.
6. A material as claimed in any of claims 2 to 5, wherein said copolymer of lactide/ c - caprolactone or lactide /glycol ide is in the form of a porous film or sheet.
7. A material as claimed in any of claims 2 to 6, wherein said copolymer of lactide/F,-caprolactone or lactide/glycolide has a dynamic modulus of elasticity in a range of 5 x 107 to 5 x 109 dynes/cml and anelongation rate of 100 to 2,000 %, both measured at room temperature (25 C).
8. A material as claimed in any of claims 2 to 7, wherein said copolymer of lactide/E -caprolactone or lactide/glycolide has its retention rate of tensile strength reduced to zero after the lapse of one to six months due to hydrolysis action in vitro in a phosphate buffer solution of 37 'C and pE 7.4.
9. A periodontium-regenerating material substantially as described in any of Examples 1 to 4.
C Publiahed 1990 at The Patent Otftce.StLte House.801-7 t F-4h Holburn. 14ndonWC1R4TP. Purther copies Maybe Obtamed, from The PatentOfflos. Sales Branch. St Mary Cray. Orpzz4%cin. Ksnt'6R5 3RD. Printed by Multiplax tealiniques ltd. St Mary Cray. Kent, CA)zk. V87
GB8918343A 1988-08-31 1989-08-11 Periodontium-regenerative materials Expired - Fee Related GB2223027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63214835A JP2709349B2 (en) 1988-08-31 1988-08-31 Materials for periodontal tissue regeneration

Publications (3)

Publication Number Publication Date
GB8918343D0 GB8918343D0 (en) 1989-09-20
GB2223027A true GB2223027A (en) 1990-03-28
GB2223027B GB2223027B (en) 1993-04-21

Family

ID=16662325

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8918343A Expired - Fee Related GB2223027B (en) 1988-08-31 1989-08-11 Periodontium-regenerative materials

Country Status (10)

Country Link
JP (1) JP2709349B2 (en)
AU (1) AU624847B2 (en)
BE (1) BE1002656A5 (en)
CA (1) CA1340354C (en)
CH (1) CH679836A5 (en)
DE (1) DE3928933C2 (en)
DK (1) DK426989A (en)
FR (1) FR2635685B1 (en)
GB (1) GB2223027B (en)
SE (1) SE503230C2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5368859A (en) * 1989-07-24 1994-11-29 Atrix Laboratories, Inc. Biodegradable system for regenerating the periodontium
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5502158A (en) * 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
WO2000001760A1 (en) * 1998-07-07 2000-01-13 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
DE19940977A1 (en) * 1999-08-28 2001-03-01 Lutz Claes Film of resorbable polymer material and process for producing such a film
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
WO2021148066A1 (en) * 2020-01-24 2021-07-29 Contipro A.S. Dental preparation comprising fibers based on hyaluronic acid with regulated biodegradability

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02152461A (en) * 1988-12-01 1990-06-12 Nippon Sogo Igaku Kenkyusho:Kk Tissue absorbable film
US5171148A (en) * 1989-06-30 1992-12-15 Ethicon, Inc. Dental inserts for treatment of periodontal disease
DE4112489C2 (en) * 1991-04-17 1994-06-09 Christian Dr Med Juergens Use of resorbable, physiologically harmless copolymers for the topical treatment of human or animal skin
DE4229924C2 (en) * 1991-04-17 1995-12-07 Juergens Christian Dr Med Use of absorbable lactide copolymers
DE4226465C2 (en) * 1991-08-10 2003-12-04 Gunze Kk Jaw bone reproductive material
FR2691901B1 (en) * 1992-06-04 1995-05-19 Centre Nat Rech Scient Use of mixtures of polymers derived from lactic acids in the preparation of bioresorbable membranes for guided tissue regeneration, in particular in periodontology.
US5576418A (en) * 1992-06-29 1996-11-19 Jurgens; Christian Resorbable biocompatible copolymers and their use
JP3257750B2 (en) * 1993-07-20 2002-02-18 エチコン・インコーポレーテツド Liquid copolymer of ε-caprolactone and lactide
DE4343988A1 (en) * 1993-12-22 1995-06-29 Peter Prof Dr Dr Diedrich Dental implant anchoring
NL9401703A (en) * 1994-10-14 1996-05-01 Rijksuniversiteit Chewing gum.
US6165217A (en) * 1997-10-02 2000-12-26 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
DE19830992C2 (en) * 1998-07-10 2000-06-08 Eckhard Binder Molded parts, especially foils, to promote the new formation of bone material in the jaw
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
JP2005046538A (en) * 2003-07-31 2005-02-24 Jms Co Ltd Porous body for medical treatment and method for manufacturing it
JP4279233B2 (en) 2004-10-25 2009-06-17 国立大学法人広島大学 Sheet for inducing mesenchymal tissue regeneration and method for producing the same
JP2011062356A (en) * 2009-09-17 2011-03-31 Gc Corp Bioabsorbable membrane for guided tissue regeneration and manufacturing method of the same
JP2017052725A (en) * 2015-09-10 2017-03-16 田畑 雅士 Blocking membranes for open wounds in dental region, and formation methods thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1332505A (en) * 1970-10-16 1973-10-03 Ethicon Inc Sutures and other surgical aids
GB1416196A (en) * 1971-11-22 1975-12-03 Ethicon Inc Process for preparing copolymers
GB2008135A (en) * 1977-11-16 1979-05-31 Ethicon Inc Lactide-glycolide block copolymers
GB2127839A (en) * 1982-10-01 1984-04-18 Ethicon Inc Surgical articles
EP0107591A2 (en) * 1982-10-22 1984-05-02 United States Surgical Corporation Absorbable surgical devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6014861A (en) * 1983-07-05 1985-01-25 株式会社日本メデイカル・サプライ Adhesion preventing material
US4578384A (en) * 1984-02-15 1986-03-25 The United States Of America As Represented By The Secretary Of The Army Polylactic-polyglycolic acids combined with an acidic phospholipid-lysozyme complex for healing osseous tissue
US4595713A (en) * 1985-01-22 1986-06-17 Hexcel Corporation Medical putty for tissue augmentation
SU1830708A1 (en) * 1989-04-27 1996-02-20 Театр полифонической драмы Device for movement of decorative equipment of information and entertainment complexes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1332505A (en) * 1970-10-16 1973-10-03 Ethicon Inc Sutures and other surgical aids
GB1416196A (en) * 1971-11-22 1975-12-03 Ethicon Inc Process for preparing copolymers
GB2008135A (en) * 1977-11-16 1979-05-31 Ethicon Inc Lactide-glycolide block copolymers
GB2127839A (en) * 1982-10-01 1984-04-18 Ethicon Inc Surgical articles
EP0107591A2 (en) * 1982-10-22 1984-05-02 United States Surgical Corporation Absorbable surgical devices

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760118A (en) * 1988-08-08 1998-06-02 Chronopol, Inc. End use applications of biodegradable polymers
US5502158A (en) * 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5599552A (en) * 1989-07-24 1997-02-04 Atrix Laboratories, Inc. Biodegradable polymer composition
US5660849A (en) * 1989-07-24 1997-08-26 Atrix Laboratories, Inc. Apparatus for forming a biodegradable implant precursor
US5368859A (en) * 1989-07-24 1994-11-29 Atrix Laboratories, Inc. Biodegradable system for regenerating the periodontium
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
WO2000001760A1 (en) * 1998-07-07 2000-01-13 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
AU746269B2 (en) * 1998-07-07 2002-04-18 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6537565B2 (en) 1998-07-07 2003-03-25 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
DE19940977A1 (en) * 1999-08-28 2001-03-01 Lutz Claes Film of resorbable polymer material and process for producing such a film
WO2021148066A1 (en) * 2020-01-24 2021-07-29 Contipro A.S. Dental preparation comprising fibers based on hyaluronic acid with regulated biodegradability

Also Published As

Publication number Publication date
AU3949089A (en) 1990-03-08
GB2223027B (en) 1993-04-21
BE1002656A5 (en) 1991-04-23
AU624847B2 (en) 1992-06-25
JPH0263465A (en) 1990-03-02
FR2635685B1 (en) 1994-10-14
FR2635685A1 (en) 1990-03-02
SE8902867L (en) 1990-03-01
DK426989D0 (en) 1989-08-30
GB8918343D0 (en) 1989-09-20
DE3928933C2 (en) 1997-08-07
JP2709349B2 (en) 1998-02-04
CA1340354C (en) 1999-01-26
SE8902867D0 (en) 1989-08-29
SE503230C2 (en) 1996-04-22
CH679836A5 (en) 1992-04-30
DK426989A (en) 1990-06-20
DE3928933A1 (en) 1990-03-01

Similar Documents

Publication Publication Date Title
US5250584A (en) Periodontium-regenerative materials
GB2223027A (en) Periodontium regenerating materials
JP4554084B2 (en) Bioabsorbable, biocompatible polymers for tissue manipulation
US5061281A (en) Bioresorbable polymers and implantation devices thereof
Piskin Biodegradable polymers as biomaterials
US5358475A (en) High molecular weight bioresorbable polymers and implantable devices thereof
ES2295021T3 (en) USE AND MEDICAL APPLICATIONS OF POLYMER POLYMERS (HYDROXIALCANOATS).
US6113624A (en) Absorbable elastomeric polymer
De Groot et al. Meniscal tissue regeneration in porous 50/50 copoly (L-lactide/ε-caprolactone) implants
US4205399A (en) Synthetic absorbable surgical devices of poly(alkylene oxalates)
JP3383492B2 (en) Absorbent polymer blend and device and method using the same
US6441073B1 (en) Biological materials
US5688900A (en) Absorbable polyalkylene diglycolates
JPH10158375A (en) Hydrogel of absorbable polyoxaester
GB1601503A (en) Synthetic absrobable surgical devices of poly(alkylene oxalates)
JPH09132639A (en) Absorbable, biocompatible segment copolymer and its production
JPH10158377A (en) Hydrogel of amine and/or amido group-containing absorbable polyoxaester
EP0908482A1 (en) Aliphatic polyesters of trimethylene carbonate Epsilon-caprolactone and glycolide
Schakenraad et al. Biocompatibility of poly (DL-lactic acid/glycine) copolymers
Yin et al. Preliminary studies on peripheral nerve regeneration using a new polyurethane conduit
Hyon et al. Melt spinning of poly-L-lactide and hydrolysis of the fiber in vitro
US6361789B1 (en) Bioresorbable material and method for producing the same
Younes et al. Biodegradable PELA block copolymers: in vitro degradation and tissue reaction
San Román et al. Partially biodegradable polyacrylic-polyester composites for internal bone fracture fixation
EP1878451A1 (en) Bioabsorbable, biocompatible polymers for tissue engineering

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20030811